Marché mondial des diagnostics in vitro immunologiques (DIV) – Tendances et prévisions de l’industrie jusqu’en 2028

Analyse et perspectives du marché des diagnostics immunologiques in vitro (DIV) : Marché mondial des diagnostics immunologiques in vitro (DIV)

Le marché des diagnostics immunologiques in vitro (IVD) devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse le marché pour représenter 23,97 milliards USD d'ici 2028 et croître à un TCAC de 4,78 % au cours de la période de prévision mentionnée ci-dessus.

Les tests de diagnostic immunologique in vitro sont généralement effectués sur des échantillons de sang ou de tissus pour identifier une maladie ou tout autre état grave. Ces appareils sont dotés de tests de séquençage de nouvelle génération qui peuvent les aider à détecter les variations génomiques dans l'ADN d'une personne.

Français L'augmentation de la population gériatrique et la forte croissance de la prévalence des maladies chroniques et infectieuses font partie des facteurs importants qui intensifient la croissance et la demande du marché des diagnostics in vitro immunologiques (DIV). En outre, l'adoption élevée d'instruments entièrement automatisés et POC dans les régions émergentes et l'augmentation de la population gériatrique contribuent également à la croissance du marché mondial au cours de la période de prévision de 2021 à 2028. De plus, la sensibilisation croissante au diagnostic des maladies et l'augmentation des investissements en R&D par les acteurs de l'industrie pour lancer de nouveaux produits DIV favorisent également la croissance du marché. En outre, l'augmentation du revenu disponible et l'expansion des systèmes de diagnostic in vitro automatisés pour les laboratoires et les hôpitaux afin de fournir un diagnostic ingénieux, précis et sans erreur sont également l'un des facteurs importants qui alimentent la croissance du marché des diagnostics in vitro immunologiques (DIV). L'augmentation de la vulnérabilité à l'acquisition de diverses maladies assurera également une forte croissance de l'industrie au cours de la période de prévision.

The rising significance of companion diagnostics, growing awareness regarding immuno in-vitro diagnostics (IVD) techniques and rapid development of condition-specific markers and tests are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.

However, the poor reimbursement scenarioand high price of the immunodiagnostic products will curb the growth of the immuno in-vitro diagnostics (IVD) market, whereas the stringent government regulations and various operational barriers faced in conducting diagnostic tests (IVD) has the potential to challenge the growth of the immuno in-vitro diagnostics (IVD) market.

This immuno in-vitro diagnostics (IVD) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on immuno in-vitro diagnostics (IVD) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Immuno In-Vitro Diagnostics (IVD) Market Scope and Market Size

Immuno in-vitro diagnostics (IVD) market is segmented on the basis of product type, immunodiagnostics technique, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of product type, the immuno in-vitro diagnostics (IVD) market is segmented into reagents, instruments, data management software and services. Instruments have further been segmented into semi-automated instruments, fully automated instruments and other instruments.
• Immuno in-vitro diagnostics (IVD) market is also segmented on the basis of immunodiagnostics technique into enzyme-linked immunosorbent assay, rapid tests, enzyme-linked immunospot assays, radioimmunoassay and western blotting. Enzyme-linked immunosorbent assay have further been segmented into chemiluminescence immunoassays, fluorescence immunoassays and colorimetric immunoassays.

Based on application, the immuno in-vitro diagnostics (IVD) market is segmented into infectious diseases, diabetes, oncology, cardiology, drug testing/pharmacogenomics, HIV/AIDS, autoimmune diseases, nephrology and others.

The end user segment of immuno in-vitro diagnostics (IVD) market is segmented into hospital laboratories, clinical laboratories, point of care testing, patient self-testing, academic institutes and others. Clinical laboratories have further been segmented into large/reference laboratories, medium-sized laboratories and small laboratories.

Immuno In-Vitro Diagnostics (IVD) Market Country Level Analysis

Immuno in-vitro diagnostics (IVD) market is analyzed and market size insights and trends are provided by country, product type, immunodiagnostics technique, application and end user as referenced above.

The countries covered in the immuno in-vitro diagnostics (IVD)market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the immuno in-vitro diagnostics (IVD) marketowing to theincreasing disease prevalence and increased consumer awareness within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of therising healthcare awareness as well as increasing patients going for early diagnosis and high chronic disease occurrence within this particular region.

The country section of the immuno in-vitro diagnostics (IVD) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Immuno in-vitro diagnostics (IVD) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for immuno in-vitro diagnostics (IVD) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the immuno in-vitro diagnostics (IVD) market. The data is available for historic period 2010 to 2019.

Analyse du paysage concurrentiel et des parts de marché des diagnostics immunologiques in vitro (DIV)

Le paysage concurrentiel du marché des diagnostics in vitro immunologiques (DIV) fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des diagnostics in vitro immunologiques (DIV).

Les principaux acteurs couverts dans le rapport sur le marché des diagnostics in vitro (DIV) immunologiques sont F. Hoffmann-La Roche Ltd, Danaher, Abbott, Siemens Healthcare Private Limited, Thermo Fisher Scientific, Inc., Johnson & Johnson Services, Inc., BD, Bio-Rad Laboratories, Inc., Sysmex Corporation, bioMérieux SA, DiaSorin SpA, Ortho Clinical Diagnostics, Agilent Technologies, Inc., QIAGEN, Bayer AG, Cepheid, Leica Biosystems Nussloch GmbH, Quidel Corporation, CARIS LIFE SCIENCES et GenomeMe, entre autres acteurs nationaux et mondiaux. Les données sur les parts de marché sont disponibles séparément pour le monde, l'Amérique du Nord, l'Europe, l'Asie-Pacifique (APAC), le Moyen-Orient et l'Afrique (MEA) et l'Amérique du Sud. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-34992